Floatz logo

18 assets in Inherited Lipid Metabolism Disorder

Therapeutic assets addressing Inherited Lipid Metabolism Disorder, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Atorvastatin
Inherited Lipid Metabolism Disorder
Johns Hopkins UniversityP4A (83)
Rosuvastatin
Inherited Lipid Metabolism Disorder
Korea University Anam HospitalP4A (81)
Metformin
Inherited Lipid Metabolism Disorder
RenJi HospitalP4BBB (78)
Ezetimibe
Inherited Lipid Metabolism Disorder
Samsung Medical CenterP4BBB (75)
Umbellatine
Inherited Lipid Metabolism Disorder
China National Center for Cardiovascular DiseasesP4BBB (72)
Liraglutide
Inherited Lipid Metabolism Disorder
RenJi HospitalP4BB (69)
Paliperidone
Inherited Lipid Metabolism Disorder
Consorcio Centro de Investigación Biomédica en Red (CIBER)P4BB (65)
Saroglitazar
Inherited Lipid Metabolism Disorder
Zydus Lifesciences LimitedP4BB (65)
Pitavastatin
Inherited Lipid Metabolism Disorder
Yonsei UniversityP3BB (64)
Bempedoic Acid
Inherited Lipid Metabolism Disorder
Priscilla Hsue, MDP2CCC (53)
Umbilical Cord Mesenchymal Stem Cell
Inherited Lipid Metabolism Disorder
Nguyen Ton Ngoc HuynhP1/2CCC (48)
Alpelisib
Inherited Lipid Metabolism Disorder
Columbia UniversityP1CC (47)
ly3885125
Inherited Lipid Metabolism Disorder
Eli Lilly and CompanyP1CC (43)
Milk Polar Lipid-Rich Dairy Powder
Inherited Lipid Metabolism Disorder
University of ConnecticutEarly P1C (39)
Lac Vaccinum
Inherited Lipid Metabolism Disorder
University of TorontoN/AD (30)
PECANS
Inherited Lipid Metabolism Disorder
University of GeorgiaN/AD (30)
Semaglutide
Inherited Lipid Metabolism Disorder
RenJi HospitalN/AD (30)